Advanced Oncotherapy PLC | Income Statement
Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
68.90
0.00
26.80
9.00
-
-
Cost of Goods Sold (COGS) incl. D&A
156.00
-
-
-
365.50
2,320.10
Gross Income
87.00
-
-
-
365.50
2,320.10
SG&A Expense
-
-
-
-
14,206.30
19,117
EBIT
-
-
7,742.30
13,184.60
14,571.80
21,437.10
Unusual Expense
1,049.40
303.60
887.10
-
-
-
Non Operating Income/Expense
257.80
359.50
151.20
106.30
79.20
362.60
Interest Expense
257.80
359.50
151.20
106.30
1,994.90
80.20
Pretax Income
3,431.10
5,699.90
8,629.40
13,184.60
16,487.50
21,866.40
Income Tax
-
-
2,784.20
2,818.10
2,827.10
759.40
Consolidated Net Income
3,431.10
5,699.90
5,845.20
10,366.60
13,660.40
21,106.90
Net Income
3,396.90
5,600.40
5,845.20
10,368.80
13,660.40
21,102.20
Net Income After Extraordinaries
2,857.60
3,737.50
5,134.80
10,390.90
13,660.40
21,054.40
Net Income Available to Common
3,939.40
7,463.30
6,555.50
10,346.70
13,660.40
21,150
EPS (Basic)
0.24
0.22
0.13
0.17
0.18
0.14
Basic Shares Outstanding
16,103.90
34,017.20
51,283.40
60,799.00
77,832.00
150,542
EPS (Diluted)
0.24
0.22
0.13
0.17
0.18
0.14
Diluted Shares Outstanding
16,103.90
34,017.20
51,283.40
60,799.00
77,832.00
150,542
EBITDA
2,299.30
5,390.10
7,708.50
12,839.20
14,206.30
21,026
Other Operating Expense
2,294.80
5,390.10
7,735.30
12,848.30
-
-
Minority Interest Expense
34.20
99.50
-
2.20
-
4.80
About Advanced Oncotherapy
View Profile
